Related Experiment Video
Updated: Oct 26, 2025

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Medicolegal Aspects of Huntington Disease
Katherine E McDonell1, Brittany K Brown2, Lisa Hale2
1Dr. McDonell, Dr. Darby, and Dr. Claassen are Assistant Professors of Neurology, Ms. Brown is Clinical Research Coordinator, and Ms. Hale is Licensed Medical Social Worker at the Department of Neurology, Vanderbilt University Medical Center. Dr. Stovall is Associate Professor of Psychiatry at the Department of Psychiatry, Vanderbilt University Medical Center. Dr. Compas is the Patricia and Rodes Hart Professor of Psychology and Human Development and Professor of Pediatrics at the Department of Psychology and Human Development, Vanderbilt University. katherine.mcdonell@vumc.org.
Abstract:
Unlawful behaviors have been reported in association with Huntington's disease (HD), although their overall prevalence and clinical significance remain unknown. Recognition of problematic behavior is limited by stigma and lack of routine clinical assessment, as well as the absence of validated screening measures. We performed a retrospective chart review of 289 patients treated for HD at Vanderbilt University Medical Center from 2006 to 2020 to assess the frequency of illegal activity in our HD population. We identified 31 patients with HD who have a documented history of unlawful behavior, comprising 11 percent of the charts reviewed. Physical violence was the most common behavior reported, followed by reckless driving, substance abuse, illegal financial activity, and inappropriate sexual behavior. Mean age at the time of the first offense was 37 years. Patients with criminal offenses were more likely to be male and in the early stages of disease with associated psychiatric symptoms. Our results emphasize that illegal activities are a significant clinical problem in individuals with HD, particularly young adult males with comorbid psychiatric symptoms. These findings highlight the need for improved screening measures to detect high-risk behaviors in individuals with HD, as well as evidence-based protocols to guide triage and management of patients engaging in potentially detrimental activities.
Related Concept Videos
Parkinson's Disease: Overview
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Hypertension III: Clinical Manifestations and Diagnostic Studies

